Share
At SynBioBeta, we strive to share not only the latest news but also inspiring stories ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Hi ,

At SynBioBeta, we strive to share not only the latest news but also inspiring stories, thought-provoking takes, and insights from the industry leaders with our digest readers. This week, we’d like to highlight a conversation between a Pulitzer Prize-winning author and a biotech investor, offer some food for thought about nourishing the world, and encourage you to rethink your morning cup of coffee. Enjoy!

I'm in Davos this week on a mission to biologize everything. I was moderating two sessions: Biologize Everything: The coming synthetic biology revolution with Sean O'Sullivan (SOSV), Gaurab Chakrabarti (Solugen), Rima Chakrabarti (KdT Ventures), and Ryan Morhard (Ginkgo Bioworks) and the session pictured below. This was a scoping mission to do something bigger next year, if you're interested in joining us then please drop me a note.

John Cumbers (SynBioBeta), Jennifer Wipf (Ginkgo Bioworks), Megan Palmer (Stanford), and Sean O'Sullivan (SOSV) at Davos.

  • Can BiologIC’s Biocomputer Help Bring Biomanufacturing to Space? BiologIC Technologies, a company out of Cambridge, UK, wants to bring disruptive innovation to biomanufacturing with the world's first biocomputer. This paradigm-shifting technology could replace traditional labs and potentially even enable biomanufacturing in space.

BiologIC Technologies’ biocomputer.

  • D.A. Wallach recently sat down with the Pulitzer Prize-winning Siddhartha Mukherjee to discuss his new book, The Song of The Cell. "It's a fantastic work, animating the history of life's ubiquitous basic unit, the cell, with vivid stories of the pioneers who drove its discovery and went on to invent modern medicine." 
  • Your dinner table will be different in 2050. "It’s important to paint a vision of what’s possible for the future," says Christine Gould, Founder and CEO of Thought for Food. "My vision and what gets me out of bed every morning is thinking about our food system that is nutritious, delicious, and sustainable."

Christine Gould. Photo by Anvita Gupta/Fast Company Middle East.

Multus Biotechnology team.

  • BioMADE is now accepting submissions for projects that address research and development priorities that will have a direct impact on mitigating the causes and consequences of global climate change.
  • Asimov, a synthetic biology company advancing the design and manufacture of therapeutics, announced a strategic partnership with Center for Breakthrough Medicines (CBM)

With 2023 officially here, we are starting the countdown to The Global Synthetic Biology Conference. Don’t forget to grab your tickets to SynBioBeta 2023! The deadline for the Digital Poster Session applications is Wednesday, February 1st, so please fill out our submission form. Don't miss your chance to showcase your innovative ideas!

SynBioBeta 2023 speakers:

  • Michael A. Fisher, Senior Fellow at Federation of American Scientists, works on U.S. science and technology policy, focusing on the bioeconomy.

  • Jocelynn Pearl is a co-founder of LabDAO and UltraRare Bio, and curates The DeSci Wiki. She is a biotech scientist, company builder, and podcaster.

  • Pau Millet Lopez is the Founder and CEO of Mirag / Double Twist Architects.

  • Christopher Hill is a co-founder of DeSci Labs. Chris is an interdisciplinary scientist who worked at the crossroads of neuroscience, economics, and machine learning. 

SynBioBeta 2023 Sponsors/Exhibitors/Partners:

  • Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development.

  • Securecell is developing innovative solutions in bioprocess technology for Biotech and BioPharma development digitalization and automation.

  • Enzymit combines a state-of-the-art computational design platform augmented with deep-learning, bringing next-gen chemistry to modern industry.

Agriculture news

Other news

Regards,
John

---

John Cumbers
Founder, SynBioBeta

Who's hiring?

View in Browser »

Like our Digest? Please feel free to share with friends, family, and co-workers!


SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences


Email Marketing by ActiveCampaign